The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1359
March 7, 2011
View Complete Issue         Table of Contents 2019 
Issue 1359
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
In Brief: FDA Warning on Dronedarone (Multaq)
March 7, 2011 (Issue: 1359)
The FDA and the manufacturer (Sanofi-Aventis) have warned healthcare professionals that use of dronedarone (Multaq), an analog of amiodarone (Cordarone, and others) approved in 2009 for treatment of atrial fibrillation,1,2 has been associated with...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1359
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.